In August 2024, experts in clinical trial research including Dr. Rohit Aggarwal, Principal Investigator of the decentralized Myositis Interstitial Lung Disease Nintedanib Trial (MINT) at the University of Pittsburgh, came together on a virtual panel to discuss the applications and benefits of deploying mobile nurse visits in an interstitial lung disease study.

Jonathan Ernst, Vice President of In-Home Solutions at PCM Trials, shared his insights on the evolving landscape of decentralized clinical trials (DCTs) in a recent interview.